![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/25/2918501/0/en/Nicox-Announces-Recruitment-of-Last-Patient-in-U-S-in-Denali-Phase-3-Trial-of-NCX-470.html
https://www.globenewswire.com/news-release/2024/07/18/2915023/0/en/Nicox-Provides-Second-Quarter-2024-Update.html
https://www.globenewswire.com/news-release/2024/07/16/2913456/0/en/Nicox-appoints-experienced-biotech-leader-Damian-Marron-as-Chair-of-the-Board-and-Marc-Le-Bozec-as-Director.html
https://www.globenewswire.com/news-release/2024/06/27/2905389/0/en/Nicox-2024-Ordinary-Shareholder-Meeting.html
https://www.globenewswire.com/news-release/2024/06/03/2891901/0/en/Number-of-voting-rights-as-of-May-31-2024.html
https://www.globenewswire.com/news-release/2024/05/06/2876001/0/en/Nicox-s-Ordinary-and-Extraordinary-Shareholders-Meeting-on-May-6-2024.html
https://www.globenewswire.com/news-release/2024/05/02/2874492/0/en/Number-of-voting-rights-as-of-April-30-2024.html
https://www.globenewswire.com/news-release/2024/04/24/2868279/0/en/Nicox-Second-notice-of-the-Ordinary-and-Extraordinary-Shareholders-Meeting-on-May-6-2024-and-appointment-of-an-ad-hoc-agent.html
https://www.globenewswire.com/news-release/2024/04/22/2866535/0/en/Nicox-Provides-First-Quarter-2024-Update-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2024/03/22/2850746/0/en/Nicox-s-Shareholder-Letter.html